The Health Ministry discovers several medications containing components connected to deadly kidney damage.
As the Indonesia looks into a rise in instances and 99 child fatalities this year, its health minister on Thursday revealed that some pharmaceutical syrups sold in Indonesia included substances related to severe acute kidney injury (AKI) in children. The Health Ministry has temporarily outlawed the sale of any drug that is a syrup and has been closely examining paracetamol syrups used locally to treat pediatric fever that include ethylene and diethylene glycol. Following 70 fatalities there, the Gambia's government is also looking into child AKI mortality connected to paracetamol syrups. India says it is looking into Maiden Pharmaceuticals Ltd., a company with its headquarters in New Delhi, which produced the syrups.
According to the Food and Drug Monitoring Agency, those specific goods were not offered locally. Health Minister Budi Gunadi Sadikin stated on Thursday that some of the patients' residences had goods with ethylene glycol and diethylene glycol in them but did not say how many. It was discovered that several syrups used by AKI pediatric kids under the age of five included ethylene glycol and diethylene glycol either in very small amounts or in excess of what was recommended. As of Thursday, Indonesia has recorded 206 instances of AKI in children, of which 99 had been fatal this year. According to Budi, there may be more cases than have been documented.A representative for the health ministry declined to reveal how many pediatric AKI patients had the chemicals found, citing the current investigation.
According to health authorities, the government will look into cases of acute renal damage, which has been blamed for the deaths of more than 20 kids in Jakarta so far this year. Authorities in the Gambia reported that over 70 children died from severe renal damage after ingesting a paracetamol syrup distributed locally for treating fever. Investigators from the World Health Organization (WHO) have discovered "unacceptable" concentrations of diethylene glycol and ethylene glycol, which can be harmful, in four items produced by Maiden Pharmaceuticals Ltd. of New Delhi. Indonesia will work with these researchers.
The syrups were not registered in the nation, the Food and Drug Monitoring Agency (BPOM) stated in a statement. According to statistics from the nation's pediatric organization (IDAI), Mohammad Syahril, a spokesman for the health ministry, told Reuters that since January, 131 cases of acute kidney damage have been reported statewide. According to him, the precise number of fatalities across the nation is yet unknown. The incidents in the Gambia, Syahril said, are unrelated to those in Indonesia. According to a separate statement from the Jakarta health department, a total of 31 instances have been documented in the city since January, with 68 percent of them ending in death.The WHO specialists looking into the Gambia issue are being contacted by the health ministry, which has also assembled a team with IDAI and a hospital in Jakarta to investigate the situation. Early research suggests intoxication may be a factor in the condition, according to the health ministry, but no clear cause has been identified. The ministry stated that more investigation was required. The manufacture of cough syrups at the Maiden facility was suspended after 12 breaches of good standards were discovered, according to Indian officials on Wednesday.
Comments
Post a Comment